Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Dr Reddy’s posts Q3 and nine months FY15 financial results
Consolidated revenues were posted at ₹38.4 billion, year-on-year growth of nine per cent
Indoco Remedies Q3 PAT grows by 53 per cent
Net revenues during the quarter under review grew by 13 per cent to Rs 212.9 crores as against Rs 188.4 crores for the same period…
Opinion: Prof Brook K Baker on the impact of US pressure to change India’s IP laws
Prof Brook K Baker, Professor of Law and Northeastern University, cautions that the Modi government’s accelerating flirtation with…
Telangana CM lays foundation stone of Shantha’s Rs 460-cr facility
The state-of-the-art facility will be built at Muppireddipalli to manufacture Sanofi’s Insuman, a human insulin for diabetes…
Ajanta Pharma posts standalone and third quarter results
Board of Directors has approved sub-division of nominal value of equity shares of the company from Rs 5 each to nominal value of…
Express Pharma (Vol.10, No.7) February 01-15, 2015
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the…
Ranbaxy loses six months exclusivity for stomach drug
Esomeprazole is used for treatment of certain stomach and esophagus problems such as acid reflux and ulcers
PHARM Connect Congress to be held in Budapest, Hungary on February 25-26, 2015
400 senior decision makers together from over 23 countries with more than 35 solution provider companies
The bigger picture vs the nitty-gritty
While we are urged to look beyond the sticky issues, one cannot overlook the final impact of decisions on India's IPR policy
AIGMF reiterates stand on unhindered supply of glass bottles to pharma cos
Approaches the Ministry of Health and Family Welfare about its capabilities and capacity to supply glass bottles to the pharma…